New Board

Mallinckrodt Completes Financial Restructuring and Irish Examinership Proceedings and Emerges From Chapter 11

Retrieved on: 
Tuesday, November 14, 2023
EBITDA, Food and Drug Administration, Corporation, Independent monitoring board, Food, New Board, LLP, Chairperson, Silver Point Capital, Patient, FDA, Specialty, Trust, Latham & Watkins, Growth, Guggenheim Partners, The Company, Adrenocorticotropic hormone (medication), AlixPartners, Alpha Metallurgical Resources, Pharmaceutical industry, Management, Mallinckrodt, Ajman Specialty General Hospital

DUBLIN, Nov. 14, 2023 /PRNewswire/ -- Mallinckrodt plc ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today announced that it has completed its financial restructuring, emerged from Chapter 11 following an expedited court-supervised process and completed the Irish Examinership Proceedings.

Key Points: 
  • DUBLIN, Nov. 14, 2023 /PRNewswire/ -- Mallinckrodt plc ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today announced that it has completed its financial restructuring, emerged from Chapter 11 following an expedited court-supervised process and completed the Irish Examinership Proceedings.
  • Supported by an enhanced capital structure, Mallinckrodt will continue to focus on advancing its business across its portfolio and executing on recent and planned product launches.
  • The Company's Specialty Generics segment benefits from vertical integration and high-quality U.S.-based manufacturing plants that have supported strong growth.
  • Latham & Watkins LLP, Wachtell, Lipton, Rosen & Katz, Arthur Cox LLP, Richards, Layton & Finger PA, and Hogan Lovells US LLP served as Mallinckrodt's counsel.

Mallinckrodt Completes Financial Restructuring and Irish Examinership Proceedings and Emerges From Chapter 11

Retrieved on: 
Tuesday, November 14, 2023
EBITDA, Food and Drug Administration, Corporation, Independent monitoring board, Food, New Board, LLP, Chairperson, Silver Point Capital, Patient, FDA, Specialty, Trust, Latham & Watkins, Growth, Guggenheim Partners, The Company, Adrenocorticotropic hormone (medication), AlixPartners, Alpha Metallurgical Resources, Pharmaceutical industry, Management, Mallinckrodt, Ajman Specialty General Hospital

DUBLIN, Nov. 14, 2023 /PRNewswire/ -- Mallinckrodt plc ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today announced that it has completed its financial restructuring, emerged from Chapter 11 following an expedited court-supervised process and completed the Irish Examinership Proceedings.

Key Points: 
  • DUBLIN, Nov. 14, 2023 /PRNewswire/ -- Mallinckrodt plc ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today announced that it has completed its financial restructuring, emerged from Chapter 11 following an expedited court-supervised process and completed the Irish Examinership Proceedings.
  • Supported by an enhanced capital structure, Mallinckrodt will continue to focus on advancing its business across its portfolio and executing on recent and planned product launches.
  • The Company's Specialty Generics segment benefits from vertical integration and high-quality U.S.-based manufacturing plants that have supported strong growth.
  • Latham & Watkins LLP, Wachtell, Lipton, Rosen & Katz, Arthur Cox LLP, Richards, Layton & Finger PA, and Hogan Lovells US LLP served as Mallinckrodt's counsel.

Leading Executives in Finance and Healthcare Marketing Join Cancer Hope Network's Board of Trustees

Retrieved on: 
Thursday, October 12, 2023
Technical Guidelines Development Committee, Investment, Knowledge, Financial audit, National Audit Office (United Kingdom), Acquisition, Hope, Trading Houses, CHN, International Financial Reporting Standards, World Services Group, Ethics in pharmaceutical sales, Cancer, United Nations Industrial Development Organization, The Conference Board, Love, Control, Marketing, Growth, Sarbanes–Oxley Act, Joe Weider, New Board, Volunteering, Olesin, World energy supply and consumption, Construction, International, Accounting, Management, Trustee

CHESTER, N.J., Oct. 12, 2023 /PRNewswire-PRWeb/ -- Cancer Hope Network (CHN) announces the addition of two distinguished professionals to its Board of Trustees: Mike Olesin, Senior Audit Partner at Deloitte & Touche LLP, and Michael Byrnes, Chief Client Officer at InStep Health. Their unique expertise and passion for positively impacting the lives of those affected by cancer will make them key drivers of CHN's mission.

Key Points: 
  • Their unique expertise and passion for positively impacting the lives of those affected by cancer will make them key drivers of CHN's mission.
  • "We are thrilled to have these two distinguished executives joining us on the Board of Trustees," said Terri-Ann Feindt, Board Chairperson and Chief Executive Officer at CHN.
  • Byrnes' tenure as one of the company's top five executives spans over 15 years, and his background in marketing and pharmaceuticals, coupled with his commitment to improving patient outcomes, make him a valuable addition to CHN's Board of Trustees.
  • "I want to express my heartfelt gratitude for the warm welcome and the opportunity to serve on the Board of Trustees," said Byrnes.

Cardiovascular Organizations Pursue New, Independent Medical Board

Retrieved on: 
Thursday, September 21, 2023
CME, Learning, ACC, Cardiac electrophysiology, Society, FHRS, Internal medicine, HRS, American Heart Association, American Board of Medical Specialties, ABMS, SCAI, American Board of Internal Medicine, FACC, Cardiology, Continuing medical education, Doctor of Philosophy, AHA, Certification, Organization, Medical specialty, American Board of Commissioners for Foreign Missions, New Board, Patient, Physician, Heart Failure Society of America, Knowledge, American College, Maintenance of Certification, Maintenance, Nursing, MD

WASHINGTON, Sept. 21, 2023 /PRNewswire/ -- Many of the nation's most prominent cardiovascular organizations, representing tens of thousands of physicians, unite today to pursue the creation of a new Board for cardiovascular medicine. The proposed new Board would be independent of the American Board of Internal Medicine, where the cardiology certification process currently exists. Collectively, the American College of Cardiology (ACC), Heart Failure Society of America (HFSA), Heart Rhythm Society (HRS) and Society for Cardiovascular Angiography & Interventions (SCAI) are working together to submit a new Board application, with potential for additional consortium members to join.

Key Points: 
  • WASHINGTON, Sept. 21, 2023 /PRNewswire/ -- Many of the nation's most prominent cardiovascular organizations, representing tens of thousands of physicians, unite today to pursue the creation of a new Board for cardiovascular medicine.
  • The proposed new Board would be independent of the American Board of Internal Medicine, where the cardiology certification process currently exists.
  • "We know that the cardiovascular community is ready for an independent, self-governed entity, and we are proud to develop this new Board with cardiologists and cardiology organizations at the helm."
  • Together, the consortium will submit an application to the American Board of Medical Specialties (ABMS), requesting an independent medical Board for cardiovascular medicine to pursue a new competency-based approach to continuous certification—one that harnesses the knowledge, skills and attitudes required to sustain professional excellence and care for cardiovascular patients effectively.

15316171 Canada Inc. Acquires Control of Over 5% of the Shares of Search Minerals Inc. and Intends to Seek Board and Management Changes

Retrieved on: 
Thursday, September 7, 2023
REE, Communication, Petros Molyviatis, TSX Venture Exchange, British Columbia Securities Commission, BCSC, File, University of São Paulo, CAD, AGM, Mass meeting, Meeting, Jubilee Holdings Limited, Shareholder, Toyota Canada Inc., Government, New Board, Investment, Risk, National instrument, Mining, National Instrument 43-101, Management, Letter, News, Disruptive Behavior Disorders Rating Scale, Annual general meeting, Security (finance), Holding company, SEARCH

The Shareholder has beneficial ownership of and\or voting control and direction over an aggregate of 26,579,635 common shares (the "Shares"), representing approximately 6.38 % of the total issued and outstanding common shares of SEARCH.

Key Points: 
  • The Shareholder has beneficial ownership of and\or voting control and direction over an aggregate of 26,579,635 common shares (the "Shares"), representing approximately 6.38 % of the total issued and outstanding common shares of SEARCH.
  • In the Shareholder's view, the SEARCH Board is not an independent board, as George Molyviatis and Jocelyn Bennett are the principals of InCoR Holdings Limited.
  • which owns appropriately 95M shares or 22.92 %, and as per the Company's news release of March 6, 2023, Dr. David Dreisinger is also not independent.
  • The Shareholder is convinced that a new Board of Directors is critical to align the interests of shareholders and management.

MoneyGram Announces New Board of Directors to Support Next Chapter of Growth as a Global Fintech Leader

Retrieved on: 
Tuesday, August 15, 2023
Stellar, Fintech, Partnership, MoneyGram, Financial services, SDF, Partner, Madison Dearborn Partners, Global Payments, Risk management, HSBC Finance, Former, Sustainability Accounting Standards Board, New Board, Electronic Arts, Mehta, CFO, Knowledge, Growth, Ecosystem, MDP, Intermedia, Bruzzo, TransUnion, EVO, Management

DALLAS, Aug. 15, 2023 /PRNewswire/ -- MoneyGram International, Inc. ("MoneyGram" or the "Company"), a leading global financial technology company that connects the world's communities, today announced its new Board of Directors. MoneyGram's new Board is composed of a diverse mix of global industry leaders with deep experience in the payments, financial services and technology industries that will help guide the Company's digital innovation strategy.

Key Points: 
  • DALLAS, Aug. 15, 2023 /PRNewswire/ -- MoneyGram International, Inc. ("MoneyGram" or the "Company"), a leading global financial technology company that connects the world's communities, today announced its new Board of Directors.
  • The new Board will leverage its deep expertise to help MoneyGram further enhance its digital business and market-leading cross-border capabilities.
  • "Now, as a private company and with the guidance of our new Board of Directors, MoneyGram is well-equipped to strengthen its position as a leading global fintech platform that connects the world's communities," said Alex Holmes, Chief Executive Officer at MoneyGram.
  • "We greatly appreciate MDP's partnership and support in constructing our new, highly capable Board with complementary expertise across the payments, financial services and technology industries.

Kitchen Culture: Business Update on Outstanding Legacy Issues and Strategy to Move Forward

Retrieved on: 
Monday, August 7, 2023
New Board, NOC, Company secretary, ACRA, CDL, Failure, Companies Act 2006, Sponsor, Bank statement, Accounting and Corporate Regulatory Authority, Telephone, Disclosure, AGM, EGM, AIA Tower, Negotiation, S.A.C. Capital Advisors, Risk, Companies Act, Growth, Annual report, Accounting, Management, Cryptocurrency, Audit, Security (finance)

The Company has also not filed its annual return with ACRA within the timelines required under the Companies Act;

Key Points: 
  • The Company has also not filed its annual return with ACRA within the timelines required under the Companies Act;
    f. a previous internal audit conducted by Baker Tilly Consultancy (Singapore) Pte.
  • "The Company is committed to addressing the significant challenges and legacy issues inherited from the previous Board in a positive and transparent manner, with full accountability to our shareholders.
  • We look forward to working closely with all stakeholders to ensure a successful future for the Company", added Mdm Hao.
  • This media release has been reviewed by the Company's sponsor, SAC Capital Private Limited (the "Sponsor").

ONUG Introduces New Board and Enhanced Steering Committee: Boosting Network and Security Teams for Enterprise Cloud Infrastructure

Retrieved on: 
Wednesday, July 26, 2023
Cloud, Petek, HSBC, Social networking service, Private, FedEx, Government Emergency Telecommunications Service, Microsoft, Human, Network as a service, Fidelity Investments, Cigna, Forum of Incident Response and Security Teams, New Board, Raytheon Technologies, Working Group, Community, Cisco, Google Cloud, Growth, Azure, Creative industries, Network equipment provider, Management, Mobile phone

ONUG: New Board and Enhanced Steering Committee: Boosting Network and Security Teams for Enterprise Cloud Infrastructure

Key Points: 
  • ONUG: New Board and Enhanced Steering Committee: Boosting Network and Security Teams for Enterprise Cloud Infrastructure
    ONUG welcomes Petek Ergul, Managing Director, Global Head of Telecommunication Services - HSBC, to its esteemed ONUG Board.
  • The ONUG Board comprises top enterprise technology leaders who set the direction for the initiatives that will best serve the interests of our ONUG member companies.
  • "We are delighted to welcome Petek Ergul to the ONUG Board," said Nick Lippis, Chairman and Co-Founder of ONUG.
  • "The Hyperscaler Network and Security Steering Committee will play a pivotal role in driving collaboration and advancing the state of enterprise IT."

Parexel Announces Updates to Board of Directors

Retrieved on: 
Friday, June 23, 2023
Columbia University, ChromeOS, Interim, Private equity, Kettering University, Goldman, University, Goldman Sachs, Mechanical engineering, MBA, Parexel, Hill-Rom, Mechanical, New Board, EQT, XRAY, Acquisition, Patient, IT University of Copenhagen, Growth, Cornell University, Economics, LRQA, Copenhagen, Security (finance), Management, Pharmaceutical industry, Health care

New Board members bring strong mix of investment, financial and industry expertise to advance company’s patients-first focus and deliver on its strategic roadmap.

Key Points: 
  • New Board members bring strong mix of investment, financial and industry expertise to advance company’s patients-first focus and deliver on its strategic roadmap.
  • I look forward to working alongside Michael, John and the entire Parexel Board and leadership team to advance these priorities and deliver on our strategic roadmap.”
    Sheri McCoy, Chairperson of the Board, added, “We are delighted to welcome Michael and John to the Parexel Board.
  • Mr. Bruun serves on the Boards of Directors at Advania, GS Wyvern, LRQA, Norgine and Northvolt.
  • In addition to Mr. Bruun and Mr. Groetelaars, Parexel’s Board of Directors includes:
    Mr. Eric Liu, Partner, Head of North American Private Equity and Global Co-Head of Healthcare, EQT

Sernova Announces Executive Alignment and Appoints New Board Chair

Retrieved on: 
Wednesday, May 31, 2023
New Board, Partnership, Professional Football Compensation Committee, FSE, T1D, Eye, PSH, AGM, American Diabetes Association, TSX, Management, Rare, Haemophilia, Chair, Security (finance), Pharmaceutical industry

Following the recent 2023 Annual General Meeting of Shareholders (the “AGM”), the Sernova Board welcomed Mr. Brett Whalen, Dr. Steven Sangha and Mr. Bertram von Plettenberg as newly elected Directors.

Key Points: 
  • Following the recent 2023 Annual General Meeting of Shareholders (the “AGM”), the Sernova Board welcomed Mr. Brett Whalen, Dr. Steven Sangha and Mr. Bertram von Plettenberg as newly elected Directors.
  • “As newly appointed Chair, I would like to welcome Dr. Sangha and Mr. von Plettenberg,” said Mr. Whalen.
  • “As a long-standing shareholder and newly elected Board member, I am excited to take on the role as Chair.
  • We are pleased to note a change in tone and energy resulting from the new Board composition.